Interestingly, treatment with growth hormone during controlled ovarian stimulation in lean women with PCOS (with hyperandrogenism and insulin resistance) was associated with a reduction in ROS levels back to the levels observed in non-PCOS patients [133]. The gene discussed is GH1; the disease is polycystic ovary syndrome.